Additional pre-clinical studies are necessary in order to verify the efficacy of this drugs on ALS-TDP43 while the present data strongly support the use of this extract to counteract the ALS-symptoms in humans. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.